Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
[NEW YORK] In its quest to defend against a US$53 billion hostile takeover, Allergan pulled back the veil on the usually secretive world of mergers and acquisitions banking on Monday.
Reiterating its belief that the business model of Valeant Pharmaceuticals is unsustainable, Botox-maker...